What This Document Is
This document is a simulation overview for the Carl Shapiro case study, designed for use in the Medical-Surgical Nursing I (NURS 1050) course at Austin Peay State University. It outlines the patient’s presentation – angina and coronary artery disease – and details the initial physician’s orders for treatment and monitoring. It serves as a preparatory guide for a hands-on simulation exercise.
Why This Document Matters
This overview is essential for students preparing to participate in a high-fidelity patient simulation. It’s used *before* the simulation to familiarize learners with the patient’s condition, expected interventions, and critical considerations. Understanding this information beforehand allows students to focus on clinical judgment, prioritization, and teamwork during the simulation itself, rather than struggling with basic patient data. It’s particularly valuable for practicing initial assessment and emergency medication administration skills.
Common Limitations or Challenges
This document provides a snapshot of the *beginning* of the patient’s case. It does not include the full patient history, evolving symptoms, or potential complications that will unfold during the simulation. It’s a starting point, not a comprehensive case study. It also doesn’t replace the need for foundational knowledge of angina, coronary artery disease, and related medications.
What This Document Provides
This overview includes:
* Patient demographics (age, gender, weight, allergies).
* A list of initial physician orders (ECG, saline, oxygen, cardiac monitoring, medications, labs).
* Key considerations for administering nitroglycerin, including potential side effects and monitoring parameters.
* Important safety information regarding morphine administration, including contraindications and adverse reactions.
* A checklist of essential pre-intervention and ongoing assessment tasks (vital signs, ECG, patient identification, lung auscultation).
This preview *does not* include the full simulation scenario, the patient’s complete medical history, or the expected outcomes of interventions. It also does not provide detailed pharmacological explanations beyond what is directly relevant to safe administration.